or
forgot password
  • cancer clinical trials in detroit, MI

  • Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
    Wayne State University

    Trial Locations
    Wayne State University
    Saint John Hospital and Medical Center
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Mixed Childhood Rhabdomyosarcoma, Pleomorphic Childhood Rhabdomyosarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma
    Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
    Barbara Ann Karmanos Cancer Institute
    Detroit, Michigan 48201
    Cognitive/Functional Effects, Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Everolimus and Octreotide With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
    Saint John Hospital and Medical Center
    Detroit, Michigan 48236
    Gastrinoma, Glucagonoma, Insulinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Recurrent Islet Cell Carcinoma, Recurrent Pancreatic Cancer, Somatostatinoma, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
    Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
    Wayne State University

    Trial Locations
    Wayne State University
    Saint John Hospital and Medical Center
    Adult Supratentorial Primitive Neuroectodermal Tumor (PNET), Childhood Supratentorial Primitive Neuroectodermal Tumor, Ewing Sarcoma of Bone, Extraosseous Ewing Sarcoma, Extraosseous Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Peripheral Primitive Neuroectodermal Tumor of the Kidney, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM)
    John D. Dingell VA Medical Center, Detroit, MI
    Detroit, Michigan 48201
    Colorectal Cancer
    Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma
    Henry Ford Health System

    Trial Locations
    Henry Ford Health System
    Local Institution
    Multiple Myeloma
    Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer
    Saint John Hospital and Medical Center
    Detroit, Michigan 48236
    Recurrent Uterine Sarcoma, Uterine Carcinosarcoma
    A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
    Karmanos Cancer Institute
    Detroit, Michigan 48201
    Multiple Myeloma, Plasma Cell Leukemia
    Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
    Saint John Hospital and Medical Center
    Detroit, Michigan 48236
    Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer
    Dose Escalation Trial of Denileukin Diftitox (Ontak) Post Autologous Transplantation
    Barbara Ann Karmanos Cancer Institute
    Detroit, Michigan 48201
    Multiple Myeloma
    Phase 1 and 2 Study of PX-866 and Cetuximab
    Karmanos Cancer Institute
    Detroit, Michigan 48201
    Incurable Metastatic Colorectal Carcinoma, Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
    Aldesleukin With or Without Aflibercept in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    Barbara Ann Karmanos Cancer Institute
    Detroit, Michigan 48201
    Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    A Study of Ultrasonography With Elastography in Skin Neoplasms
    Wayne State University
    Detroit, Michigan 48202
    Benign and Malignant Skin Neoplasms
    Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer
    Saint John Hospital and Medical Center
    Detroit, Michigan 48236
    Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Recurrent Esophageal Cancer, Recurrent Gastric Cancer
    IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma
    Karmanos Cancer Institute
    Detroit, Michigan 48201
    Metastatic Renal Cell Carcinoma
    Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction
    Karmanos Cancer Institute
    Detroit, Michigan 48201
    Neoplasms, Lymphomas
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Henry Ford Hospital

    Trial Locations
    Henry Ford Hospital
    Wayne State University
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Saint John Hospital and Medical Center
    Detroit, Michigan 48236
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Exercise and Stress Management Post Autologous and Allogeneic Transplant
    Karmanos Cancer Institute
    Detroit, Michigan 48201
    Physiological Stress
    Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast Cancer
    Barbara Ann Karmanos Cancer Institute
    Detroit, Michigan 48201
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)
    Karmanos Cancer Institute
    Detroit, Michigan 48201
    Advanced Malignancies, B-Cell Lymphoma, Solid Tumor, Positive for Anaplastic Lymphoma Kinase, Positive for Proto-Oncogene Tyrosine-Protein Kinase ROS
    A Study of DS-2248, in Subjects With Advanced Solid Tumors
    Wayne State University Department of Oncology Karmanos Cancer Institute
    Detroit, Michigan 48201
    Solid Tumors, Non-small Cell Lung Carcinoma
    Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors
    Karmanos Cancer Center
    Detroit, Michigan 48201
    Advanced Solid Malignant Tumors, Advanced Ovarian Cancer
    Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
    Wayne State University/Karmanos Cancer Institute Wayne St Karmanos
    Detroit, Michigan 48201
    Non-small Cell Lung Cancer
    Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
    Josephine Ford Cancer Center at Henry Ford Hospital
    Detroit, Michigan 48202
    Head and Neck Cancer, Precancerous Condition
    A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
    Henry Ford Health System
    Detroit, Michigan 48202
    Acute Myeloid Leukemia
    Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer
    Karmanos Cancer Center
    Detroit, Michigan 48201
    Breast Cancer
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    Henry Ford Hospital

    Trial Locations
    Henry Ford Hospital
    Karmanos Cancer Institute
    Advanced Prostate Cancer, Prostatic Neoplasms
    S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy
    Barbara Ann Karmanos Cancer Institute

    Trial Locations
    Barbara Ann Karmanos Cancer Institute
    Josephine Ford Cancer Center at Henry Ford Hospital
    Prostate Cancer
    A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
    Karmanos Cancer Center
    Detroit, Michigan 48201
    Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Cancer, Malignant Tumor of Renal Pelvis
    A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
    Henry Ford Hospital Henry Ford
    Detroit, Michigan 48202
    Basal Cell Carcinoma
    Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma
    Henry Ford Health System

    Trial Locations
    Henry Ford Health System
    Local Institution
    Multiple Myeloma
    S0820, Adenoma and Second Primary Prevention Trial
    Wayne State University

    Trial Locations
    Wayne State University
    Saint John Hospital and Medical Center
    Colorectal Neoplasms
    A Study of Oral LGK974 in Patients With Malignancies Dependent on Wnt Ligands
    Wayne State University/Karmanos Cancer Institute Wayne St
    Detroit, Michigan 48201
    Melanoma, Breast Neoplasms, Lobular Carcinoma, Triple-negative Breast Cancer, Pancreatic Adenocarcinoma
    A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
    Children's Hospital of Michigan

    Trial Locations
    Children's Hospital of Michigan
    Henry Ford Health System
    Karmanos Cancer Institute
    Hematological Malignancies, Certain Lysosomal Storage and Peroxisomal Enzyme Deficiency Disorders, Hurler Syndrome (MPS I), Krabbe Disease (Globoid Leukodystrophy), X-linked Adrenoleukodystrophy, Primary Immunodeficiency Diseases, Bone Marrow Failure, Beta-thalassemia
    Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.
    Henry Ford Health System

    Trial Locations
    Henry Ford Health System
    Karmanos Cancer Center
    Multiple Myeloma, Non-Hodgkin Lymphoma, Glioblastoma Multiforme, Squamous Cell Carcinoma of Head and Neck, Prostate Cancer, Ewing's Osteosarcoma, Chronic Lymphocytic Leukemia